# OnCo record nct02883049 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02883049/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02883049", "NCT02883049" ;
  schema:name "Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations"@en ;
  schema:description "A phase 3 trial of Clofarabine, Cyclophosphamide, Cytarabine, Dasatinib, Daunorubicin, Dexamethasone, Doxorubicin, Etoposide, Leucovorin, Mercaptopurine, Methotrexate, Asparaginase, Prednisone, Thioguanine and Vincristine in Acute lymphoblastic leukaemia and Leukaemia, run by National Cancer Institute (NCI), completed."@en ;
  schema:url <https://onco.cc/trials/nct02883049/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02883049> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/leukaemia/> ;
  onco:drugs <https://onco.cc/drugs/clofarabine/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/cytarabine/>, <https://onco.cc/drugs/dasatinib/>, <https://onco.cc/drugs/daunorubicin/>, <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/leucovorin/>, <https://onco.cc/drugs/mercaptopurine/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/asparaginase/>, <https://onco.cc/drugs/prednisone/>, <https://onco.cc/drugs/thioguanine/>, <https://onco.cc/drugs/vincristine/> .